ESR2 and neoplasm: When concurrent with ERα, ERβ commonly shows an antagonism against tumor proliferation and invasion (23), reflected in a restrained output of ERα and its mediated transcriptional activities by the decreasing recruitment of c-Fos and c-Jun to the estrogen response promotor (24).